Capital Of “Bank Prometey” To Increase By 50% Due To The New Russian Shareholder

YEREVAN, February 7. /ARKA/. In 2011 charter capital of Armenian Bank Prometey Ltd will increase by 50% or 3.6 billion drams making 10.8 billion drams due to the third shareholder with right of voice by 33.33% – Russian company “Prometey-City”.

Decision on increasing the charter capital of the Bank was adopted on February 3 in the extraordinary meeting of shareholders of “Bank Prometey”.

At present, shareholders of the Bank are Zakneftgasstroy Prometey open jsc (92.25%) and Vazgen Gevorgyan (Russia) – 7.75%.

Bank Prometey Ltd was established in 1990 and registered on October 2, 1991. On October 31, 1996 the Bank got general license of CB Armenia №27.

As of December 31, 2010 the assets of the Bank were 27.5 billion drams, liabilities – 17.2 billion drams, total capital – 10.3 billion drams, credit investments – 15.9 billion drams, liabilities to the clients – 7.8 billion drams and net income – by the results of 2010 – 671.6 million drams.

The Bank has four branches as of December 31. ($1- 364.71 drams). –0–

spot_img

POPULAR

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

LATEST NEWS

spot_imgspot_imgspot_img